✦ LIBER ✦

N0147: A Randomized Phase III Trial of Oxaliplatin plus 5-Fluorouracil/Leucovorin with or Without Cetuximab After Curative Resection of Stage III Colon Cancer

✍ Scribed by Steven R. Alberts; Frank A. Sinicrope; Axel Grothey

Book ID: 119934998
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 96 KB
Volume: 5
Category: Article
ISSN: 1533-0028
DOI: 10.3816/ccc.2005.n.033

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oxaliplatin, fluorouracil, and leucovori

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

✍ Taieb, Julien; Tabernero, Josep; Mini, Enrico; Subtil, Fabien; Folprecht, Gunnar 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 466 KB

Comparison of FOLFIRI With or Without Ce

Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147

✍ Huang, Jocelin; Nair, Suresh G.; Mahoney, Michelle R.; Nelson, Garth D.; Shields 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 423 KB

Severe enteropathy among patients with s

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin : A prospective analysis

✍ J. Philip Kuebler; Linda Colangelo; Michael J. O'Connell; Roy E. Smith; Greg Yot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract ## BACKGROUND. Cases of severe gastrointestinal toxicity were monitored prospectively during NSABP C‐07, a randomized clinical trial of adjuvant therapy for patients with stage II/III colon cancer. ## METHODS. Patients were treated with weekly bolus 5‐fluorouracil (5‐FU) and leucovor

Randomized Phase III Trial of Concurrent

Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

✍ Ang, K. K.; Zhang, Q.; Rosenthal, D. I.; Nguyen-Tan, P. F.; Sherman, E. J.; Webe 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 637 KB

A randomised phase III intergroup trial

A randomised phase III intergroup trial comparing high-dose infusional 5-fluorouracil with or without folinic acid with standard bolus 5-fluorouracil/folinic acid in the adjuvant treatment of stage III colon cancer: The Pan-European Trial in Adjuvant Colon Cancer 2 study

✍ Köhne, Claus-Henning; Bedenne, Laurent; Carrato, Alfredo; Bouché, Olivier; Popov 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 373 KB

Adjuvant chemotherapy with oxaliplatin,

Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB